Sep. 19, 2012—The protein Syk is essential for clearing away neuron “corpses” in the developing peripheral nervous system.
Sep. 6, 2012—Inhibitory neurons that connect and regulate signaling in the brain (interneurons) may contribute to epilepsy and autism in patients with tuberous sclerosis complex.
Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
Jun. 14, 2012—Cells in the back of the developing brain can give rise to brain tumors, suggesting they may be a target for treatment.
May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.
Mar. 9, 2012—Some patients may need a combo of medications to combat a condition that causes dizziness.
Feb. 1, 2012—Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.
Jan. 5, 2012—Managing myocardial infarction – and the resulting heart failure – remains a clinical challenge. To search for chemicals that can stimulate cardiac muscle cell production, Vanderbilt Institute of Chemical Biology investigators led by Tao Zhong, Ph.D., Terri Ni, Ph.D., and Eric Rellinger, M.D., turned to a novel drug discovery tool: zebrafish. The researchers visually screened...
Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.
Sep. 29, 2011—Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.
Apr. 27, 2011—A zebrafish model of the genetic disease tuberous sclerosis complex will speed new discoveries.
Mar. 17, 2011—Patients with certain autonomic nervous system disorders have impaired odor identification, which could aid in diagnosis.